Linked from

The 15 pages that link to CAR T-cell therapy, each with the reason it gives.

• Gene therapyRelated: It is a prominent ex-vivo gene therapy that equips immune cells with a synthetic receptor.

• T cellBroader topic: It redesigns T-cell recognition to attack certain cancers.

• LymphocyteRelated: It redirects a patient's lymphocytes toward cancer cells.

• Genetic engineeringRelated: Engineered immune cells demonstrate a direct therapeutic use in patients.

• ImmunotherapyBroader topic: It redirects T cells toward cancer cells by giving them synthetic antigen receptors.

• Regenerative medicineCompared with: It is a cell therapy, but its primary aim is targeted killing rather than tissue regeneration.

• Adaptive immune systemBroader topic: It redirects adaptive immune cells toward selected cancer antigens.

• Cancer immunotherapyBroader topic: It directly equips T cells to recognize selected cancer antigens.

• Cytokine stormRelated: Its powerful immune activation can cause cytokine release syndrome.

• Genome editingRelated: Genome editing can alter immune cells to improve or broaden their therapeutic function.

• Cell therapyBroader topic: It has produced durable remissions in some blood cancers.

• HematologyRelated: Its success in some blood cancers is balanced by serious toxicities and uneven availability.

• Johnson & JohnsonRelated: Johnson & Johnson markets Carvykti, a CAR-T therapy for multiple myeloma.

• History of genetic engineeringBroader topic: It demonstrates genetic engineering applied to living human immune cells.

• Immune system phenomenaBroader topic: It is a specific intervention that redirects cellular immune attack.